API Holdings Limited (Pharmeasy), as per its annual filings, is engaged in the business of undertaking and/or arranging or syndicating all types of business relating to the financing of industry or corporates like logistic and IT sectors. Further, during the year under review, the company had transferred its businesses of wholesale and distribution of drugs (including pharmaceutical products, medical devices, and OTC drugs) and ownership of technology and intellectual property for developing e-commerce platforms including marketplaces for facilitating the sale of pharmaceutical, medical devices, and OTC drugs to its wholly-owned subsidiaries through a slump sale on a going concern basis.
